糖尿病黄斑浮腫の世界市場2018-2022

【英語タイトル】Global Diabetic Macular Edema Treatment Market 2018-2022

Technavioが出版した調査資料(IRTNTR23639)・商品コード:IRTNTR23639
・発行会社(調査会社):Technavio
・発行日:2018年8月31日
・ページ数:109
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥740,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、糖尿病黄斑浮腫の世界市場について調査・分析し、市場概要、市場環境、糖尿病黄斑浮腫市場規模、製品種類別(抗VEGF、コルチコステロイド、その他)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。主な分析対象企業は、ALLERGAN, Alimera Sciences, Bausch Health, F. Hoffmann-La Roche, Regeneron Pharmaceuticalsなどです。
・エグゼクティブサマリー
・調査範囲・調査手法
・糖尿病黄斑浮腫の世界市場概要
・糖尿病黄斑浮腫の世界市場環境
・糖尿病黄斑浮腫の世界市場動向
・糖尿病黄斑浮腫の世界市場規模
・糖尿病黄斑浮腫の世界市場:業界構造分析
・糖尿病黄斑浮腫の世界市場:製品種類別(抗VEGF、コルチコステロイド、その他)
・糖尿病黄斑浮腫の世界市場:地域別市場規模・分析
・糖尿病黄斑浮腫の北米市場規模・予測
・糖尿病黄斑浮腫のヨーロッパ・中東・アフリカ市場規模・予測
・糖尿病黄斑浮腫のアジア太平洋市場規模・予測
・糖尿病黄斑浮腫の主要国分析
・糖尿病黄斑浮腫の世界市場:意思決定フレームワーク
・糖尿病黄斑浮腫の世界市場:成長要因、課題
・糖尿病黄斑浮腫の世界市場:競争環境
・糖尿病黄斑浮腫の世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About Diabetic Macular Edema
Diabetic macular edema is an accumulation of fluid in the macula, a part of the retina that controls most of the detailed vision abilities, due to leaking blood vessels.
Technavio’s analysts forecast the Global Diabetic Macular Edema Treatment Market to grow at a CAGR of 1.45% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the diabetic macular edema treatment market. To calculate the market size, the report considers the revenue generated by sales of therapeutics for diabetic macular edema across the globe.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, diabetic macular edema treatment market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• ALLERGAN
• Alimera Sciences
• Bausch Health
• F. Hoffmann-La Roche
• Regeneron Pharmaceuticals
Market driver
• Increase in R&D investments by pharmaceutical companies
• For a full, detailed list, view our report

Market challenge
• Lack of awareness
• For a full, detailed list, view our report

Market trend
• Use of new laser delivery systems
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: PIPELINE LANDSCAPE
PART 08: MARKET SEGMENTATION BY PRODUCT TYPE
• Segmentation by product type
• Comparison by product type
• Anti-VEGF – Market size and forecast 2017-2022
• Corticosteroid – Market size and forecast 2017-2022
• Others – Market size and forecast 2017-2022
• Market opportunity by product type
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• ALLERGAN
• Alimera Sciences
• Bausch Health
• F. Hoffmann-La Roche
• Regeneron Pharmaceuticals
PART 16: APPENDIX
• List of abbreviations

Exhibit 01: Parent market
Exhibit 02: Global diabetic macular edema treatment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global diabetic macular edema treatment market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global diabetic macular edema treatment market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Key clinical trial candidates for the treatment of diabetic macular edema
Exhibit 19: Key clinical trial candidates for the treatment of diabetic macular edema
Exhibit 20: Comparison by product type
Exhibit 21: Anti-VEGF – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Anti-VEGF – Year-over-year growth 2018-2022 (%)
Exhibit 23: Corticosteroid – Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Corticosteroid – Year-over-year growth 2018-2022 (%)
Exhibit 25: Others – Market size and forecast 2017-2022 ($ mn)
Exhibit 26: Others – Year-over-year growth 2018-2022 (%)
Exhibit 27: Market opportunity by product type
Exhibit 28: Customer landscape
Exhibit 29: Global diabetic macular edema treatment market by geography – Market share 2017-2022 (%)
Exhibit 30: Regional comparison
Exhibit 31: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top 3 countries in Americas
Exhibit 34: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top 3 countries in EMEA
Exhibit 37: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 38: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 39: Top 3 countries in APAC
Exhibit 40: Market opportunity
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: ALLERGAN: Overview
Exhibit 47: ALLERGAN – Business segments
Exhibit 48: ALLERGAN – Organizational development
Exhibit 49: ALLERGAN – Geographic focus
Exhibit 50: ALLERGAN – Segment focus
Exhibit 51: ALLERGAN – Key offerings
Exhibit 52: ALLERGAN – Key customers
Exhibit 53: Alimera Sciences: Overview
Exhibit 54: Alimera Sciences – Business segments
Exhibit 55: Alimera Sciences – Organizational developments
Exhibit 56: Alimera Sciences – Segment focus
Exhibit 57: Alimera Sciences – Key offerings
Exhibit 58: Alimera Sciences – Key customers
Exhibit 59: Bausch Health: Overview
Exhibit 60: Bausch Health – Business segments
Exhibit 61: Bausch Health – Organizational developments
Exhibit 62: Bausch Health – Geographic focus
Exhibit 63: Bausch Health – Segment focus
Exhibit 64: Bausch Health – Key offerings
Exhibit 65: Bausch Health – Key customers
Exhibit 66: F. Hoffmann-La Roche: Overview
Exhibit 67: F. Hoffmann-La Roche – Business segments
Exhibit 68: F. Hoffmann-La Roche – Organizational developments
Exhibit 69: F. Hoffmann-La Roche – Geographic focus
Exhibit 70: F. Hoffmann-La Roche – Segment focus
Exhibit 71: F. Hoffmann-La Roche – Key offerings
Exhibit 72: F. Hoffmann-La Roche – Key customers
Exhibit 73: Regeneron Pharmaceuticals: Overview
Exhibit 74: Regeneron Pharmaceuticals – Business segments
Exhibit 75: Regeneron Pharmaceuticals – Organizational development
Exhibit 76: Regeneron Pharmaceuticals – Segment focus
Exhibit 77: Regeneron Pharmaceuticals – Key offerings
Exhibit 78: Regeneron Pharmaceuticals – Key customers



【掲載企業】

ALLERGAN, Alimera Sciences, Bausch Health, F. Hoffmann-La Roche, Regeneron Pharmaceuticals

★調査レポート[糖尿病黄斑浮腫の世界市場2018-2022] (コード:IRTNTR23639)販売に関する免責事項を必ずご確認ください。
★調査レポート[糖尿病黄斑浮腫の世界市場2018-2022]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆